Apogee Therapeutics Financial Overview
Apogee Therapeutics's market cap is currently $5.16B. The company's EPS TTM is $-1.11; its P/E ratio is -17.91; Apogee Therapeutics is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-1.00. See an overview of income statement, balance sheet, and cash flow financials.
